40 results on '"Silvestri, G.A."'
Search Results
2. Elevated BMI Predicts Poor Lung Cancer Screening Outcomes Independent of Diabetes Mellitus in a National Lung Screening Trial Subgroup (n=18,463)
3. Overtreatment and Competing Causes of Death: Does This Contribute to Poor Outcomes in the National Lung Screening Trial (N=18,463)
4. Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial
5. Poor Lung Cancer Screening Outcomes Was Associated With Diabetes in a National Lung Screening Trial Subgroup (N=18,463)
6. Assessment of an Integrated Classifier's Ability to Distinguish Benign From Malignant Nodules: Subgroup Analysis of the Oracle Registry
7. A Multicenter, Prospective Trial Assessing the Diagnostic Yield of Electromagnetic Bronchoscopic and Transthoracic Navigation for Peripheral Pulmonary Nodules
8. Poor Lung Cancer Screening Outcomes Was Associated With Chronic Bronchitis in a National Lung Screening Trial Subgroup (n=18,463)
9. Improved Lung Cancer Detection in Setting of Underutilized CT Screening: Combination of a Lung Cancer Biomarker With Clinical Risk Assessment
10. EP.04C.07 A Novel NGS Assay Using cfDNA Methylation for Early Detection of Lung Cancer in a Screen-Eligible Population
11. Lung Cancer Is Just Different: Comparing the Social Determinants and Baseline Health of Patients with Lung, Colon, and Breast Cancer
12. Predictors of Smoking Cessation in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial
13. Smokers Undergoing Lung Cancer Screening with Diagnosed COPD Suffer the Highest Mortality Including Similar Cardiovascular Mortality as Diabetic
14. MA10.06 Factors Associated with Lung Cancer Screening Adherence Among Patients with Negative Baseline Nodule Finding
15. Changes in Quality of Life in Lung Cancer Survivors: Trend and Predictors
16. Demographic Differences in Those Being Screened for Lung Cancer and the Implications for Mass Screening in the U.S.
17. Clinical Evaluation of the Thin TCP-EBUS Bronchoscopy System (Thin EBUS Pilot Study)
18. 189P Design and enrollment for a classifier development study for a blood-based multi-cancer early detection (MCED) test
19. Correlating Depth of Sedation with Vital Signs and Adverse Events in Bronchoscopy
20. Genetic Risk Score (GRS) and Lung Cancer Biology Affect Lung Cancer Screening Outcomes
21. Development and Validation of a Bronchoscopic Yield Prediction Model
22. Comparison of Low Dose Chest CT Screening Guidelines Within an Occupational Cohort Setting
23. Gender, Competing Deaths and Outcomes from Lung Cancer Screening in the National Lung Screening Trial (NLST)
24. Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017
25. Carcinoma of the bronchus 60 years later
26. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules
27. Carcinoma of the bronchus 60 years later
28. Comparing the Efficacy and Safety of Remimazolam Versus Midazolam Based on Age and ASA Class in Sedation for Bronchoscopy
29. Multicenter, Prospective Pilot and Feasibility Study of Robotic Assisted Bronchoscopy for Peripheral Pulmonary Lesions
30. Lung Cancer Risk (PLCOm2012) and Surgical Rates for Lung Cancer in a Post-Hoc Analysis of the National Lung Screening Trial (NLST-ACRIN, N=10,054)
31. Filtered, Unfiltered, Light, Ultralight, Regular or Mentholated: The Effect of Cigarette Type on Lung Cancer Incidence and Mortality in the National Lung Screening Trial
32. Lung Cancer Risk (PLCOm2012) and Pre-Existing Respiratory Morbidity in a Post-Hoc Analysis of the National Lung Screening Trial (NLST-ACRIN, N=10,054)
33. Genetic Susceptibility to Lung Cancer and COPD in the National Lung Screening Trial (NLST): COPD Masks AGER Gene Susceptibility to Lung Cancer
34. Long-Term Efficacy and Safety of Bronchial Thermoplasty (BT): 4 Year Follow-Up Results from a Large Scale Prospective Study
35. Genetic Susceptibility to Lung Cancer and COPD in the National Lung Screening Trial: The Differing Role of Genes Conferring Risk in the Screening Setting
36. Cost-effectiveness of CT screening in the national lung screening trial
37. A tale of two cities: comparing lung cancer outcomes in Teesside, UK and Varese, Italy
38. Accuracy of EUS criteria and primary tumor site for identification of mediastinal lymph node metastasis from non-small-cell lung cancer
39. Patient Beliefs about Lung Cancer Surgery.
40. The clinical evaluation for detecting metastatic lung cancer: A meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.